Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Total Current Liabilities (2016 - 2021)

Phio Pharmaceuticals' Total Current Liabilities history spans 10 years, with the latest figure at $2.5 million for Q3 2021.

  • For Q3 2021, Total Current Liabilities rose 11.88% year-over-year to $2.5 million; the TTM value through Sep 2021 reached $2.5 million, up 11.88%, while the annual FY2020 figure was $2.2 million, 16.81% up from the prior year.
  • Total Current Liabilities reached $2.5 million in Q3 2021 per PHIO's latest filing, down from $2.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $2.8 million in Q2 2018 to a low of $1.5 million in Q1 2019.
  • Average Total Current Liabilities over 5 years is $2.2 million, with a median of $2.2 million recorded in 2020.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 85.5% in 2017, then crashed 39.91% in 2019.
  • A 5-year view of Total Current Liabilities shows it stood at $2.3 million in 2017, then fell by 23.0% to $1.7 million in 2018, then rose by 7.8% to $1.9 million in 2019, then rose by 16.81% to $2.2 million in 2020, then rose by 13.62% to $2.5 million in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Total Current Liabilities are $2.5 million (Q3 2021), $2.6 million (Q2 2021), and $2.2 million (Q1 2021).